Acute Events in Children with Sickle Cell Disease in Italy During the COVID-19 Pandemic: Useful Lessons Learned

Roy N, Telfer P, Eleftheriou P, de la Fuente J, Drasar E, Shah F . Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic. Br J Haematol. 2020; 189(4):635-639. PMC: 7264776. DOI: 10.1111/bjh.16687. View

Arlet J, De Luna G, Khimoud D, Odievre M, De Montalembert M, Joseph L . Prognosis of patients with sickle cell disease and COVID-19: a French experience. Lancet Haematol. 2020; 7(9):e632-e634. PMC: 7302791. DOI: 10.1016/S2352-3026(20)30204-0. View

Megna R . First month of the epidemic caused by COVID-19 in Italy: current status and real-time outbreak development forecast. Glob Health Res Policy. 2020; 5:43. PMC: 7544517. DOI: 10.1186/s41256-020-00170-3. View

Colombatti R, Palazzi G, Masera N, Notarangelo L, Bonetti E, Samperi P . Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey. Pediatr Blood Cancer. 2017; 65(2). DOI: 10.1002/pbc.26774. View

Sainati L, Biffi A . How we deal with the COVID-19 epidemic in an Italian paediatric onco-haematology clinic located in a region with a high density of cases. Br J Haematol. 2020; 189(4):640-642. PMC: 7262185. DOI: 10.1111/bjh.16699. View

Po C, Colombatti R, Cirigliano A, Da Dalt L, Agosto C, Benini F . The management of sickle cell pain in the emergency department: a priority for health systems. Clin J Pain. 2012; 29(1):60-3. DOI: 10.1097/AJP.0b013e318245764b. View

Lubrano R, Villani A, Berrettini S, Caione P, Chiara A, Costantino A . Point of view of the Italians pediatric scientific societies about the pediatric care during the COVID-19 lockdown: what has changed and future prospects for restarting. Ital J Pediatr. 2020; 46(1):142. PMC: 7531060. DOI: 10.1186/s13052-020-00907-3. View

Appiah-Kubi A, Acharya S, Fein Levy C, Vlachos A, Ostovar G, Murphy K . Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases. Br J Haematol. 2020; 190(4):e221-e224. PMC: 7405127. DOI: 10.1111/bjh.17013. View

Ferraro V, Zamunaro A, Spaggiari S, Di Riso D, Zanconato S, Carraro S . Pediatric asthma control during the COVID-19 pandemic. Immun Inflamm Dis. 2021; 9(2):561-568. PMC: 8014816. DOI: 10.1002/iid3.418. View

10.

Colombatti R, Perrotta S, Samperi P, Casale M, Masera N, Palazzi G . Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhood. Orphanet J Rare Dis. 2013; 8:169. PMC: 4231397. DOI: 10.1186/1750-1172-8-169. View

11.

Piel F, Steinberg M, Rees D . Sickle Cell Disease. N Engl J Med. 2017; 376(16):1561-1573. DOI: 10.1056/NEJMra1510865. View

12.

Lazzerini M, Barbi E, Apicella A, Marchetti F, Cardinale F, Trobia G . Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health. 2020; 4(5):e10-e11. PMC: 7146704. DOI: 10.1016/S2352-4642(20)30108-5. View